Table 3.
Circadian rhythm parameters (mean ± s.e.m.) of all clock genes, AANAT, and melatonin in overexpression treatments, as determined by cosinor analyses.
| Group | BMAL1 | BMAL2 | CLOCK | BMAL1 | CLOCK | CRY1 | CRY2 | PER2 | PER3 | AANAT | Melatonin | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mesor (×10−3) | p-BMAL1 | ND | 70.64 ± 6.62* | 2.36 ± 0.14* | ND | 0.31 ± 0.07 | ND | ND | 1.22 ± 0.05(×103)* | 23.27 ± 4.18* | ND | ND |
| p-CLOCK | 3.44 ± 0.18 | 3.52 ± 0.56 | ND | 0.46 ± 0.07 | ND | ND | ND | 4.21 ± 0.00* | 2.55 ± 0.11* | 7.27 ± 0.66 | 175.17 ± 3.51 | |
| pcDNA3.1 | 3.49 ± 0.15 | 3.43 ± 0.30 | 4.04 ± 0.02 | 0.43 ± 0.15 | 0.29 ± 0.09 | 30.39 ± 1.65 | 2.93 ± 0.29 | 2.62 ± 0.20 | 1.98 ± 0.13 | 7.32 ± 1.10 | 156.13 ± 19.14 | |
| Amplitude (×10−3) | p-BMAL1 | ND | 38.21 ± 0.87* | 1.83 ± 0.09* | ND | 0.24 ± 0.03 | ND | ND | 0.16 ± 0.02(×103)* | 22.56 ± 3.92* | ND | ND |
| p-BMAL1 | 1.03 ± 0.05* | 1.74 ± 0.61 | ND | 0.18 ± 0.03 | ND | ND | ND | 1.12 ± 0.00 | 0.98 ± 0.10 | 7.17 ± 0.32* | 60.08 ± 1.97 | |
| pcDNA3.1 | 1.53 ± 0.06 | 1.75 ± 0.02 | 3.88 ± 0.17 | 0.14 ± 0.05 | 0.23 ± 0.04 | 10.41 ± 1.8 | 1.19 ± 0.10 | 1.13 ± 0.05 | 1.01 ± 0.08 | 5.33 ± 0.24 | 55.31 ± 9.65 | |
| Acrophase (h) | p-BMAL1 | ND | 9.12 ± 0.08* | 12.70 ± 0.32* | ND | 14.04 ± 0.12* | ND | ND | 2.74 ± 0.09* | 5.67 ± 0.23* | ND | ND |
| p-CLOCK | 15.31 ± 0.72* | 15.95 ± 0.77 | ND | 19.14 ± 0.20* | ND | ND | ND | 19.86 ± 1.01* | 22.16 ± 0.09 | 18.36 ± 0.42 | 21.45 ± 0.09* | |
| pcDNA3.1 | 13.51 ± 0.17 | 15.35 ± 0.25 | 15.05 ± 0.18 | 14.45 ± 1.05 | 15.39 ± 0.23 | 21.71 ± 0.27 | 16.54 ± 0.46 | 22.18 ± 0.59 | 22.34 ± 0.36 | 18.31 ± 0.50 | 19.13 ± 0.31 | |
| R2 | p-BMAL1 | 0.37 | 0.80 | 0.63 | 0.37 | 0.85 | 0.28 | 0.27 | 0.65 | 0.77 | 0.06 | 0.08 |
| p-CLOCK | 0.62 | 0.57 | 0.34 | 0.56 | 0.17 | 0.38 | 0.15 | 0.53 | 0.52 | 0.86 | 0.81 | |
| pcDNA3.1 | 0.80 | 0.97 | 0.86 | 0.83 | 0.72 | 0.86 | 0.68 | 0.85 | 0.83 | 0.95 | 0.99 | |
| P | p-BMAL1 | 0.13 | 0.00 | 0.00 | 0.48 | 0.01 | 0.21 | 0.24 | 0.00 | 0.00 | 0.86 | 0.80 |
| p-CLOCK | 0.00 | 0.01 | 0.13 | 0.05 | 0.52 | 0.07 | 0.51 | 0.01 | 0.01 | 0.00 | 0.00 | |
| pcDNA3.1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| F | p-BMAL1 | 2.31 | 17.32 | 7.88 | 0.96 | 11.71 | 1.72 | 1.61 | 7.58 | 15.30 | 0.25 | 0.34 |
| p-CLOCK | 7.72 | 6.18 | 2.26 | 3.80 | 0.80 | 2.86 | 0.80 | 5.21 | 5.15 | 29.75 | 15.67 | |
| pcDNA3.1 | 41.67 | 371.68 | 42.12 | 35.60 | 21.49 | 39.79 | 12.18 | 43.48 | 36.08 | 194.50 | 254.87 |
Note: p-BMAL1 represents the overexpression BMAL1 group, p-CLOCK represents the overexpression CLOCK group. ND represents not determined as there was no circadian rhythm. Significant differences (P < 0.05) between the treatment and pcDNA3.1 groups are shown by an asterisk (*).
This work is licensed under a